Health Sciences Group, Inc.

HESGOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$1870936

P/E Ratio—

52W High$0.0001

52W Low$0.000001

Avg Volume1.3M

Open$0.00

Beta2.24

Overview

Health Sciences Group, Inc. (HESG) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

HESG · free cash flow · updated Jun 15, 2026

Core FCF metrics

HESG · FCF · TTM · margin & CAGR

Free cash flow was $41,990 for FY2012 (fiscal year ending 2012-12-31), up 101.0% year-over-year The FCF margin was 11.7%.

FY2012 Free Cash Flow$41,990▲ +101.0% YoY

Trailing 12M (TTM)−$544,125Trailing 4Q sum · TTM negative vs latest FY positive

FCF Margin11.7%$41,990 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

HESG · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2012Latest$41,992(0M)$41,990▲ +101.0%11.7%

FY2005−$3.7M(0M)−$4.1M▼ 287.9%—

FY2004−$1.1M(0M)−$1.1M▲ +14.7%—

FY2003−$1.1M(0M)−$1.2M▼ 101.5%-23.1%

FY2002−$595,812(0M)−$615,165▼ 66.2%-11.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

HESG · P/FCF · FCF yield · FCF per share

Health Sciences Group, Inc. (HESG) valuation ratios are currently unavailable — market cap, share count, or TTM data could not be retrieved from our data provider.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

Valuation ratios are unavailable — market cap, share count, or TTM data could not be retrieved. Individual metrics are shown where available.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2012 · 2012-12-31

Cash flow statement summary

HESG · cash flow statement · operating / investing / financing

For FY2012, Health Sciences Group, Inc. generated $0.0M in operating cash flow and spent 0M in capital expenditures, yielding $0.0M in free cash flow.

Operating Activities

+$0.0M

Cash from core business operations

2012-12-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2012-12-31

Financing Activities

−$0.0M

Buybacks, dividends & debt

2012-12-31

FCF FormulaOperating CF ($0.0M) − |CapEx| (0M) = FCF ($0.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

HESG vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Health Sciences Group, Inc.YOU

HESG

$41,990+101.0%11.7%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Health Sciences Group, Inc. (HESG) reported free cash flow of $41,990 for FY2012 (fiscal year ending 2012-12-31), up 101.0% year-over-year. The FCF margin was 11.7%.

Based on available data, Health Sciences Group, Inc. has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $41,990 in FY2012.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

HESG free cash flow · 8 questions

Health Sciences Group, Inc. free cash flow was $41,990 for FY2012, up 101.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$544,125.

HESG free cash flowHESG FCFHESG FCF 2012HESG free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Health Sciences Group, Inc. · Health Sciences Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026